Steve Jobs to Take New Medical Leave from Apple

Steve Jobs, CEO and co-founder of Apple and the most well-known member of the carcinoid and neuroendocrine tumor community, is taking a new medical leave of absence.  This announcement was reported today, January 17, 2011, by The New York Times, a year and a half after Jobs’ liver transplant.   Jobs was diagnosed with an islet cell pancreatic neuroendocrine tumor (NET) in 2004 for which he had surgery, followed by a liver transplant.

Steve Jobs to take new medical leave from Apple

Jobs talked publicly about his liver transplant on March 20, 2010 “for the first time at a press conference where then California Governor Arnold Schwarzenegger introduced new legislation to encourage and make easier organ donation.”  Watch Steve Jobs talking about his liver transplant here:

If you are interested in learning more about carcinoid and other neuroendocrine cancers, such as pancreatic neuroendocrine tumors, please visit the Carcinoid Cancer Foundation’s website at To read more about pancreatic NETs  CLICK HERE and also use the Search feature located at the top of every page for additional references.

You can also download the PowerPoint presentation about islet tumor cells of the pancreas by Michael J. Demeure, MD, MBA.  Dr. Demeure is the Director of the Endocrine Tumor Center at Scottsdale Healthcare and Senior Investigator at TGen (Translational Genomics Institute) Clinical Research Service in Arizona.

Contributions to the Carcinoid Cancer Foundation make a significant difference in how we can help people with pancreatic NETs, carcinoid, and other neuroendocrine tumors.  We are dedicated to helping bring about greater awareness of these cancers, to educating the medical community and the general public to look for, diagnose, and treat these diseases early; and to serving as advocates for the carcinoid/NET community throughout the world. Join us as we REACH for a Cure Research, Education, and Awareness with Compassion and Hope — for carcinoid and neuroendocrine cancer patients.

Print Friendly, PDF & Email